Group Chief Financial Officer
Mark Beards is the Group CFO and CFO of Celixir plc. He most recently served as Director of Life Sciences Strategy at KPMG and is former Head of Healthcare Equity Research at Goldman Sachs. Mark has worked in commercial roles at GSK and Abbott Laboratories, and supported a diverse range of life science organisations whilst at McKinsey & Company. He is a Chartered Management Accountant.